Nanoparticles show potential as part of new therapy for advanced ovarian cancer

Links shared publicly online about this topic.

1,859
total visits

Nanoparticles show potential as part of new therapy for advanced ovarian cancer

Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.

View full resource at news-medical.net

Tags: Diphtheria, Cancer, Ovarian Cancer, Women's Health